BMS-986172

N/A

Report date: 2023/09/20 13:24:54
NME

Base Information

Drug NameBMS-986172
Drug Alias NameBMS-986172
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitors
TargetsAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb Sl
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A